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Mutations in the KCNQ2 gene, encoding a potassium channel subunit, were reported
in patients presenting epileptic phenotypes of varying severity. Patients affected by
benign familial neonatal epilepsy (BFNE) are at the milder end of the spectrum, they
are affected by early onset epilepsy but their subsequent neurological development is
usually normal. Mutations causing BFNE are often inherited from affected parents.
Early infantile epileptic encephalopathy type 7 (EIEE7) is at the other end of the
severity spectrum and, although EIEE7 patients have early onset epilepsy too, their
neurological development is impaired and they will present motor and intellectual
deficiency. EIEE7 mutations occur de novo. Electrophysiological experiments
suggested a correlation between the type of mutation and the severity of the disease
but intra and interfamilial heterogeneity exist. Here, we describe the identification of
KCNQ2 mutation carriers who had children affected with a severe epileptic
phenotype, and found that these individuals were mosaic for the KCNQ2 mutation.
These findings have important consequences for genetic counseling and indicate that
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